In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS

Microvascular dysfunction in type 2 diabetic patients with normal rest-stress myocardial perfusion imaging

Session Poster session III

Speaker Gustavo Javier Daquarti

Event : ICNC, Nuclear Cardiology & Cardiac CT 2019

  • Topic : imaging
  • Sub-topic : Single Photon Emission Computed Tomography (SPECT)
  • Session type : Poster Session

Authors : G Daquarti (Buenos Aires,AR), H Sanabria (Buenos Aires,AR), D Rosa (Buenos Aires,AR), M Cornelli (Buenos Aires,AR), M Gobbo (Buenos Aires,AR), C Rapallo (Buenos Aires,AR), M Vera (Buenos Aires,AR), E Aguirre (Buenos Aires,AR), D Coronel (Buenos Aires,AR), N Blanco (Buenos Aires,AR), N Perez Balino (Buenos Aires,AR), O Masoli (Buenos Aires,AR), A Meretta (Buenos Aires,AR)

Authors:
G Daquarti1 , H Sanabria1 , D Rosa1 , M Cornelli1 , M Gobbo1 , C Rapallo1 , M Vera1 , E Aguirre1 , D Coronel1 , N Blanco1 , N Perez Balino1 , O Masoli1 , A Meretta1 , 1Cardiovascular Institute of Buenos Aires (ICBA) - Buenos Aires - Argentina ,

Citation:

Background: Diabetes mellitus is associated with high risk of coronary artery disease. Coronary microvascular dysfunction (CMD) leads an increased risk of cardiovascular events in diabetic patients even in absence of epicardial coronary artery disease or normal perfusion rest-stress studies. With the new Cadmium Zinc Telluride (CZT) Gamma Cameras, high resolution gated spect images are obtained and coronary flow reserve (CFR) assessment can be done using Technetium-99m based perfusion tracers. 

Purpose: The aim of this study was to investigate the prevalence of CMD in type 2 diabetic patients
with normal rest-stress myocardial perfusion imaging using CZT-Spect.

Methods: 40 type 2 diabetic patients without history of cardiovascular disease were referred for gated spect perfusion dipyridamole rest-stress test and CFR assessment with DSpect® using Tc-99m MIBI. Normal perfusion images were defined visually by consensus of two experimented nuclear cardiologists and compared with normal database.  CFR was obtained by stress / rest flow ratio with 4DM® software. CMD was defined as CFR < 2.  Relationships between CFR and glycated haemoglobin, LDL-cholesterol and systolic blood pressure were determined. 

Results: Median CFR in diabetic patients was lower than healthy controls (1.86 vs 2.58; p<0,001). The prevalence of CMD in diabetics was 53% with gender differences between groups (table). No significant correlations between CFR,  glycated haemoglobin, LDL-cholesterol or systolic blood pressure were found.

Conclusion: We found a high prevalence of CMD in type 2 diabetic patients with normal rest-stress perfusion study. Females are more affected than men.

Group with microvascular dysfunction (n=21) Group without microvascular dysfunction (n=19) p
Age, years (IQ 25-75) 66 (57-75) 63 (57-67) 0.231
Male gender 5 (23%) 16 (84%) <0.001
Diabetes duration, years (IQ 25-75) 10 (3-10) 8 (5-11) 0.888

Glycated haemoglobin, % (IQ 25-75)

6.9 (6.5-7.7) 6.9 (5.8-7.8) 0.503
Smoking 3 (14%) 1 (5%) 0.739
Systolic blood pressure, mmHg (IQ 25-75) 125 (120-141) 130 (125-138) 0.557
LDL-cholesterol, mg/dL (IQ 25-75) 94 (60-128) 102 (71-132) 0.520
Body mass index, Kg/m2 (IQ 25-75) 31 (27-38) 29 (28-32) 0.433
Coronay flow reserve, mL/g/min (IQ 25-75) 1.63 (1.37-1.79) 2.48 (2.14-2.84) <0.001

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are